Research ArticleArticle
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
Molecular Pharmacology April 2, 2020, mol.119.118539; DOI: https://doi.org/10.1124/mol.119.118539
Vivian W.Y. Liao
1 The University of Sydney;
Anuradha Kumari
2 IIT Bombay;
Rajeshwar Narlawar
1 The University of Sydney;
Soma Vignarajan
1 The University of Sydney;
David E. Hibbs
1 The University of Sydney;
Dulal Panda
3 Indian Institute of Technology Bombay
Paul W. Groundwater
1 The University of Sydney;
Jump to comment:
No eLetters have been published for this article.
In this issue
Molecular Pharmacology
Vol. 105, Issue 4
1 Apr 2024
Research ArticleArticle
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
Molecular Pharmacology April 2, 2020, mol.119.118539; DOI: https://doi.org/10.1124/mol.119.118539
Research ArticleArticle
Tubulin-Binding 3,5-Bis(styryl)pyrazoles as Lead Compounds for the Treatment of Castration-Resistant Prostate Cancer
Vivian W.Y. Liao, Anuradha Kumari, Rajeshwar Narlawar, Soma Vignarajan, David E. Hibbs, Dulal Panda and Paul W. Groundwater
Molecular Pharmacology April 2, 2020, mol.119.118539; DOI: https://doi.org/10.1124/mol.119.118539
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement